David Kennedy, MD
Otolaryngology · Philadelphia, PANPI 1528090644
Payments from drug & device makers
What this record shows
The money is spread across several categories — royalties or licence payments (42.0%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Medtronic at 50.6% of the total. 2025 is the largest year on record at $212,794, 3.5 times the $61,043 reported in 2019. Among otolaryngology clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 253 payments — averaging $2382.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$305K
- Sanofi$80K
- Aerin Medical Inc.$74K
- Regeneron Healthcare Solutions, Inc.$48K
- Stryker$41K
- GSK$29K
- plus $25K from 9 others
What the payments were for
- Royalty or licence$252,99142%
- Consulting fees$150,90925%
- Speaking & faculty fees$170,50228%
- Travel & lodging$19,1353%
- Food & beverage$9,1662%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 80 | $304,962 |
| Sanofi | 43 | $80,268 |
| Aerin Medical Inc. | 35 | $73,993 |
| Regeneron Healthcare Solutions, Inc. | 24 | $48,437 |
| Stryker | 25 | $40,936 |
| GSK | 10 | $29,161 |
| Intersect ENT, Inc. | 8 | $12,725 |
| Fiagon NA LLC | 2 | $9,000 |
| Optinose US, Inc. | 10 | $1,939 |
| Integra Lifesciences Corporation | 5 | $566 |
| Regeneron | 3 | $293 |
| Acclarent, Inc | 4 | $259 |
| Neurent Medical Limited | 2 | $67 |
| Johnson & Johnson | 1 | $61 |
| Biocryst US Sales Co., LLC | 1 | $35 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Sophono$180,753
- DUPIXENT$159,944
- VIVAER STYLUS$73,235
- NUVENT$64,144
- XPRESS ENT DILATION SYSTEM$39,237
- STEALTHSTATION S8 PLATFORM$30,238
- SHAVER SYSTEM$20,150
- SCOPIS ENT$18,532
- CORE$16,900
- SONOPET IQ$16,900
- TGS GUIDEWIRE$16,900
- StealthStation$14,215
- NUCALA$8,689
- STRAIGHTSHOT$2,400
- FUSION$2,130
- Xhance$1,765
- RHINAER STYLUS$1,499
- ORTHOMAP$650
- PROPEL$646
- Acclarent Aera$541
How this compares
$602,702 in reported general payments places this provider in the 95th percentile of 456 otolaryngology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Olopatadine Hcl | 19 | $1,095 |
| Azelastine Hcl | 33 | $820 |
| Fluticasone Propionate | 36 | $569 |
| Mupirocin | 15 | $188 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Philadelphia
- Nancy SnydermanPhiladelphia$4.5M
- James PalmerPhiladelphia$331K
- Mathew NagorskyPhiladelphia$95K
- Noam CohenPhiladelphia$76K
- Nithin AdappaPhiladelphia$72K
- Steven CannadyPhiladelphia$33K
- David CognettiPhiladelphia$30K
- John KrousePhiladelphia$30K
- Soo AbboudPhiladelphia$23K
- Joseph CurryPhiladelphia$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.